Home/Filings/4/0000886163-23-000069
4//SEC Filing

Zimmermann Martine 4

Accession 0000886163-23-000069

CIK 0000886163other

Filed

Sep 25, 8:00 PM ET

Accepted

Sep 26, 4:41 PM ET

Size

7.2 KB

Accession

0000886163-23-000069

Insider Transaction Report

Form 4
Period: 2023-09-22
Transactions
  • Award

    Common Stock

    2023-09-22+2,2852,285 total
  • Award

    Employee Stock Option (right to buy)

    2023-09-22+11,34511,345 total
    Exercise: $59.08Exp: 2033-09-22Common Stock (11,345 underlying)
Footnotes (2)
  • [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three substantially equal annual installments on September 22, 2024; September 22, 2025; and September 22, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
  • [F2]Grant of Stock Options that will vest and become exercisable in three substantially equal annual installments on September 22, 2024; September 22, 2025; and September 22, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeother

Related Parties

1
  • filerCIK 0001994049

Filing Metadata

Form type
4
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 4:41 PM ET
Size
7.2 KB